10x Genomics Inc (LTS:0A88)
$ 14.72 0.6324 (4.47%) Market Cap: 1.78 Bil Enterprise Value: 1.46 Bil PE Ratio: 0 PB Ratio: 2.46 GF Score: 60/100

10X Genomics Inc at UBS Genomics 2.0 and Medtech Innovations Summit (Virtual) Transcript

Aug 12, 2020 / 03:00PM GMT
Daniel Gregory Brennan
UBS Investment Bank, Research Division - Senior Equity Research Analyst of Healthcare Life Sciences

Good afternoon or really late good morning. Dan Brennan from UBS life science tools, diagnostics and pharma services analyst. Great to be joined here on stage at day 2 of the Genomics conference with Serge Saxonov as Co-Founder, CEO of 10x Genomics who, for everyone who's dialing in, knows well. Company reported last night, so it's timely. I know in the years past, when we've tried to have Serge come, it's kind of been a week earlier, so it's been quite difficult the week before the quarter. So I'm glad that we're able to have you be here in such a timely fashion. So certainly -- well, first off, welcome, and thank you for being here.

Serge Saxonov
10x Genomics, Inc. - Co-Founder, CEO & Director

Thanks, Dan. Glad to be here.

Daniel Gregory Brennan
UBS Investment Bank, Research Division - Senior Equity Research Analyst of Healthcare Life Sciences

Terrific. Terrific. And feel free, anyone

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot